Bleeding Disorders Therapeutics Market Size, Share And Development By 2027

The global bleeding disorders therapeutics market size is set for steady expansion owing to the increasing prevalence of hemophilia in the world. According to a study led by researchers from the McMaster University in Canada, more than 1,125,000 males worldwide are suffering from inherited bleeding disorders in 2019. Approximately 418,000 of them have severe form of these diseases, the study finds. Moreover, the World Federation of Hemophilia estimates that the number of people with bleeding disorders increased sharply by 6.8% in 2017 from 2016 levels. This consistent rise in the prevalence of this disease will shape the bleeding disorders therapeutics market trends in the forecast period. More importantly, there is a dire need to develop more advanced and effective treatment options as hemophilia is an incurable disorder and preventing it is almost impossible as it is inherited and can have ethnic origins.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/bleeding-disorders-therapeutics-market-101169

Leading Players operating in the Bleeding Disorders Therapeutics Market are:

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:

China Biologic Products Holdings, Inc.
Novo Nordisk A/S
Grifols, S.A.
Shire
Pfizer, Inc.
Octapharma
Bayer AG
Kedrion S.p.A
CSL
Initiation of Programs Focused on Bleeding Disorders to Feed Market Growth

Bleeding disorders, such as hemophilia and von Willebrand, refer to conditions in which blood shows an inability to clot properly. They occur due to the absence or deficiency of any of the thirteen clotting factors that the human body produces. Owing to the growing incidence of bleeding disorders worldwide and inability of majority of those affected to seek medication, there has been a concerted global effort towards addressing this issue. For example, in 2003, the World Federation of Hemophilia (WHF) launched the Global Alliance for Progress (GAP) which primarily aimed at increasing the diagnostic and treatment capabilities to treat people with hemophilia and other bleeding disorders. The GAP initiative is gaining stride in regions where governments are unable to effectively tackle these health conditions. For instance, in April 2019, the WHF signed an MoU with the Government of Uzbekistan under the GAP framework to develop a multi-disciplinary approach for the diagnosis and treatment of hemophilia. Such initiatives will play a central role in augmenting the bleeding disorders treatment market growth.

Market Segmentation:

By Product

Plasma-Derived Coagulation Factor Concentrates
Recombinant Coagulation Factor Concentrates
Desmopressin
Anti-fibrinolytic
Fibrin Sealants
Others
By Type

Hemophilia A
Hemophilia B
Von Willebrand Disease
Others
By End Users

Hospitals
Ambulatory Surgical Centres
Specialty Clinics
Others
By Geography

North America (U.S. and Canada)
Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)
Latin America (Brazil, Mexico, and Rest of Latin America)
Middle East & Africa (South Africa, GCC, and Rest of the Middle East & Africa)

Contact us:

Fortune Business Insights Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.

Phone:

US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

This release was published on openPR.